It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Bacteria often reside in sessile communities called biofilms, where they adhere to a variety of surfaces and exist as aggregates in a viscous polymeric matrix. Biofilms are resistant to antimicrobial treatments, and are a major contributor to the persistence and chronicity of many bacterial infections. Herein, we determined that the CpxA-CpxR two-component system influenced the ability of enteropathogenic Yersinia pseudotuberculosis to develop biofilms. Mutant bacteria that accumulated the active CpxR~P isoform failed to form biofilms on plastic or on the surface of the Caenorhabditis elegans nematode. A failure to form biofilms on the worm surface prompted their survival when grown on the lawns of Y. pseudotuberculosis. Exopolysaccharide production by the hms loci is the major driver of biofilms formed by Yersinia. We used a number of molecular genetic approaches to demonstrate that active CpxR~P binds directly to the promoter regulatory elements of the hms loci to activate the repressors of hms expression and to repress the activators of hms expression. Consequently, active Cpx-signalling culminated in a loss of exopolysaccharide production. Hence, the development of Y. pseudotuberculosis biofilms on multiple surfaces is controlled by the Cpx-signalling, and at least in part this occurs through repressive effects on the Hms-dependent exopolysaccharide production.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Umeå University, Department of Molecular Biology, Umeå, Sweden (GRID:grid.12650.30) (ISNI:0000 0001 1034 3451); Umeå University, Umeå Centre for Microbial Research, Umeå, Sweden (GRID:grid.12650.30) (ISNI:0000 0001 1034 3451)
2 Umeå University, Department of Molecular Biology, Umeå, Sweden (GRID:grid.12650.30) (ISNI:0000 0001 1034 3451); Umeå University, Umeå Centre for Microbial Research, Umeå, Sweden (GRID:grid.12650.30) (ISNI:0000 0001 1034 3451); Umeå University, The Laboratory for Molecular Infection Medicine, Umeå, Sweden (GRID:grid.12650.30) (ISNI:0000 0001 1034 3451)
3 Brigham Young University, Department of Microbiology and Molecular Biology, Provo, USA (GRID:grid.253294.b) (ISNI:0000 0004 1936 9115)